Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Condensed Consolidated Statements of Operations    
Revenues $ 24,261 $ 23,285
Cost of goods sold 4,816 3,714
Gross profit 19,445 19,571
Costs and expenses:    
Sales and marketing 17,838 16,434
Research and development 4,614 4,139
General and administrative 5,502 9,201
Total costs and expenses 27,954 29,774
Loss from operations (8,509) (10,203)
Other income (expense):    
Investment income 311 716
Interest expense (31) (14)
Other expense 37 (3)
Total other income (expense), net 317 699
Net Loss $ (8,192) $ (9,504)
Weighted average common shares outstanding - basic and diluted 39,697,790 38,933,984
Loss per common share - basic and diluted $ (0.21) $ (0.24)